Outcome of Staphylococcus aureus-triggered sepsis and arthritis in IL-4-deficient mice depends on the genetic background of the host

European Journal of Immunology

Volumn 29, Issue 8, 1999, Pages 2400-2405

  Hultgren, Olof ^a   Kopf, Manfred ^b   Tarkowski, Andrzej ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

Arthritis; IL 4; Staphylococcus aureus

Indexed keywords

INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; FEMALE; GENE DISRUPTION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS AUREUS; SURVIVAL;

ANIMALS; ANTIBODIES, BACTERIAL; ARTHRITIS, INFECTIOUS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; SEPSIS; SPECIES SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032785431     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199908)29:08<2400::AID-IMMU2400>3.0.CO;2-E     Document Type: Article

References (20)

1. Esterhai, J. L and Gelb, I., Adult Septic Arthritis. Orthop. Clin. North Am. 1991. 22: 503-514.
2. Ryan, M. J., Kavanagh, R., Wall, P. G. and Hazleman, B. L., Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br. J. Rheumatol. 1997. 36: 370-373.
3. Goldenberg, D. L. and Reed, J. I., Bacterial arthritis. N. Engl. J. Med. 1985. 312: 764-771.
4. Riegels-Nielsen, P., Frimodt-Möller, N., Sörensen, M. and Jensen, J. S., Antibiotic treatment insufficient for established septic arthritis. Acta Orthop. Scand. 1989. 60: 113-115.
5. Bone, R. C., The pathogenesis of sepsis. Ann. Intern Med. 1991. 115: 457-469.
6. Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F. and Cerami, A., Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemi. Nature 1987. 330: 662-664.
7. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey III, T. J., Zentella, A., Albert, J. D., Shires, G. T. and Cerami, A., Shock and tissue injury induced by recombinant human cachectin. Science 1986. 234: 470-474.
8. Mohler, K. M., Torrance, D. S., Smith, C. A., Goodwin, R. G., Stremler, K. E., Fung, V. P., Madani, H. and Widmer, M. B., Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 1993. 151: 1548-1561.
9. Fischer, C. J., Jr., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H. and Benjamin, E., Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N. Engl. J. Med. 1996. 334: 1697-1702.
10. Baumhofer, J. M., Beinhauer, B. G., Wang, J. E., Brandmeier, H., Geissler, K., Losert, U., Philip, R., Aversa, G. and Rogy, M. A., Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur. J. Immunol. 1998. 28: 610-615.
11. Muchamuel, T., Menon, S., Pisacane, P., Howard, M. C. and Cockayne, D. A., IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia. J. Immunol. 1997. 158: 2898-2903.
12. Hultgren, O., Kopf, M. and Tarkowski, A., Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth. J. Immunol. 1998. 160: 5082-5087.
13. Hultgren, O., Eugster, H.-P., Sedgwick, J. D., Körner, H. and Tarkowski, A., TNF/LTα double mutant mice resist septic arthritis but display increased mortality in response to Staphylococcus aureus. J. Immunol. 1998. 161: 5937-5942.
14. Zhao, Y.-X., Nilsson, I.-M. and Tarkowski, A., The dual role of IFN-γ in experimental Staphylococcus aureus septicemia versus arthritis. Immunology 1997. 93: 80-85.
15. Brunet, L. R., Finkelman, F. D., Cheever, A. W., Kopf, M. A. and Pearce, E. J., IL-4 protects against TNF-α-mediated cachexia and death during acute schistosomiasis. J. Immunol. 1997. 159: 777-785.
16. Verdrengh, M. and Tarkowski, A., Role of neutrophil granulocytes in Staphylococcus aureus-induced septic shock. Infect. Immun. 1997. 65: 2517-2521.
17. Röcken, M., Racke, M. and Schevach, E. M., IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today 1996. 17: 225-231.
18. van Roon, J. A. G., van Roy, J. L. A. M., Gmelig-Meyling, F. H. J., Lafeber, F. P. J. G. and Bijlsma, J. W. J., Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum. 1996. 39: 829-835.
19. Kopf, M., Le Gros, G., Bachmann, M., Lamers, M. C., Bluethmann, H. and Köhler, G., Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993. 362: 245-248.
20. Bremell, T., Lange, S., Svensson, L., Jennische, E., Gröndahl, K., Carlsten, H. and Tarkowski, A., Outbreak of spontaneous staphylococcal arthritis and osteitis in mice. Arthritis Rheum. 1990. 33: 1739-1744.